I posted a short piece on Facebook about a week ago about new technology developments in cancer treatment. It seems that this disease is raising it’s head and making me take notice more and more because I was reading the February edition of South East Business magazine today and came across an article about an innovation from Angle PLC.
Angle PLC has been working with Surrey University to develop a blood separation technique which, if successful, in a few years’ time will be used to take a simple blood test to show people whether they are at risk from cancer.
Read the whole article here (page 20)
The main application of the Parsortix separation device (quite a name!) is with known cancer patients in identifying whether they have secondary cancers and also to select the most effective chemotherapy drug for them. Often patients are treated with three or four different drugs at the same time because cancers mutate and it isn’t known which drug will work. These drugs have awful side effects and hopefully this technology will help identify the most effective drug and therefore help reduce the side effects.
The device is in the lab at the moment undergoing tests with ‘spiked’ blood (normal blood with cancer cells added) and will be tested with cancer patient blood. The hope is that the final product will be ready for sale to research teams by the end of this year. Two years after that the device will make its way into hospitals.
Angle PLC specialise in working with large research organisations and creating businesses from them. And reducing suffering – hooray to that!